ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00135395
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : February 5, 2010
Sponsor:
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2006
  Actual Study Completion Date : February 2006
  Certification/Extension First Submitted : February 3, 2010